Literature DB >> 32346918

Direct enantioseparation of mandelic acid by high-performance liquid chromatography using a phenyl column precoated with a small amount of cyclodextrin additive in a mobile phase.

Yuri Watanabe1, Ikko Mikami1, Atsushi Yamamoto2, Sen-Ichi Aizawa3, Atsushi Taga4, Naoki Mochizuki5, Yoshimi Ishihara1, Shuji Kodama1.   

Abstract

Direct enantioseparation of mandelic acid by high-performance liquid chromatography (HPLC) with a reversed phase column and a mobile phase containing a small amount of hydroxylpropyl-β-cyclodextrin (HP-β-CD) was studied as an efficient method for saving consumption of the CD additive. As a result, it was proposed that racemic mandelic acid can be analyzed with a phenyl column by using a mobile phase composed of 10 mM ammonium acetate buffer (pH 4.2) and 0.02% (w/v) HP-β-CD at a flow rate of 1.0 mL/min at 40°C after the passage of 10 mM ammonium acetate buffer (pH 4.2) containing 0.1% (w/v) HP-β-CD as a precoating mobile phase for 60 min. It is suggested that HP-β-CD is bound with a phenyl group on the surface of the stationary phase to allow a phenyl column to act as a transient chiral column, and injected mandelic acid can form the ternary complex with the adsorbed HP-β-CD. The longer retention time of D-mandelic acid than the L-isomer for HPLC can be explained from the higher stability of the HP-β-CD complex with D-mandelic acid, which was confirmed by CE experiment with HP-β-CD as a selector. The efficiency of a phenyl column compared with other stationary phases was also discussed.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  HPLC; enantioseparation; hydroxypropyl-β-cyclodextrin; mandelic acid; phenyl column

Year:  2020        PMID: 32346918     DOI: 10.1002/chir.23228

Source DB:  PubMed          Journal:  Chirality        ISSN: 0899-0042            Impact factor:   2.437


  1 in total

1.  Chiral separation using cyclodextrins as mobile phase additives in open-tubular liquid chromatography with a pseudophase coating.

Authors:  Raymond B Yu; Joselito P Quirino
Journal:  J Sep Sci       Date:  2022-01-22       Impact factor: 3.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.